Pulmonx Corporation
NASDAQ:LUNG
7.3 (USD) • At close March 11, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 83.789 | 68.675 | 53.662 | 48.416 | 32.733 | 32.595 | 20.004 |
| Cost of Revenue
| 21.788 | 17.923 | 13.797 | 12.786 | 11.531 | 10.181 | 7.718 |
| Gross Profit
| 62.001 | 50.752 | 39.865 | 35.63 | 21.202 | 22.414 | 12.286 |
| Gross Profit Ratio
| 0.74 | 0.739 | 0.743 | 0.736 | 0.648 | 0.688 | 0.614 |
| Reseach & Development Expenses
| 17.57 | 18.08 | 15.397 | 13.063 | 7.46 | 6.049 | 6.991 |
| General & Administrative Expenses
| 0 | 89.807 | 77.005 | 64.771 | 44.574 | 34.203 | 20.347 |
| Selling & Marketing Expenses
| 0 | 4.8 | 6.1 | 5.1 | 1.5 | 0.6 | 0.1 |
| SG&A
| 102.135 | 94.607 | 83.105 | 69.871 | 46.074 | 34.203 | 20.347 |
| Other Expenses
| 0 | 0 | -0.396 | -0.585 | 3.282 | -0.617 | -0.916 |
| Operating Expenses
| 119.705 | 112.687 | 98.502 | 82.934 | 53.534 | 40.252 | 27.338 |
| Operating Income
| -57.704 | -61.935 | -58.637 | -47.304 | -32.332 | -17.838 | -15.052 |
| Operating Income Ratio
| -0.689 | -0.902 | -1.093 | -0.977 | -0.988 | -0.547 | -0.752 |
| Total Other Income Expenses Net
| 1.81 | 1.663 | 0.067 | -1.014 | 0.314 | -2.502 | -3.415 |
| Income Before Tax
| -55.894 | -60.272 | -58.57 | -48.318 | -32.018 | -20.34 | -18.467 |
| Income Before Tax Ratio
| -0.667 | -0.878 | -1.091 | -0.998 | -0.978 | -0.624 | -0.923 |
| Income Tax Expense
| 0.5 | 0.571 | 0.353 | 0.343 | 0.213 | 0.363 | 0.012 |
| Net Income
| -56.394 | -60.843 | -58.923 | -48.661 | -32.231 | -20.703 | -18.479 |
| Net Income Ratio
| -0.673 | -0.886 | -1.098 | -1.005 | -0.985 | -0.635 | -0.924 |
| EPS
| -1.44 | -1.6 | -1.59 | -1.35 | -0.9 | -0.58 | -0.89 |
| EPS Diluted
| -1.44 | -1.6 | -1.59 | -1.35 | -0.9 | -0.58 | -0.89 |
| EBITDA
| -57.704 | -55.092 | -55.991 | -46.622 | -28.437 | -16.822 | -15.677 |
| EBITDA Ratio
| -0.689 | -0.802 | -1.072 | -0.981 | -0.881 | -0.542 | -0.784 |